Li Chengqiang,Tao Cheng,Chen Jinhu,Zhu Jian,Lu Jie,Bai Tong,Zhang Guifang,Liu Tonghai,Yin Yong.The plan quality and delivery efficiency of intensity modulated radiotherapy on a new designed linac for left side breast cancer[J].Chinese Journal of Radiological Medicine and Protection,2019,39(8):614-618
The plan quality and delivery efficiency of intensity modulated radiotherapy on a new designed linac for left side breast cancer
Received:March 13, 2019  
DOI:10.3760/cma.j.issn.0254-5098.2019.08.010
KeyWords:Breast cancer  Dual layer MLC  Intensity modulated radiotherapy  Flatten filter free  Segment area
FundProject:国家自然科学基金(81472811,81671785);国家重点研发计划数字诊疗装备研发重点专项临床验证评价子课题(2016YFC0105106);山东省重点研发计划项目(2018GSF118006);山东省自然科学基金(ZR2016HQ09)
Author NameAffiliationE-mail
Li Chengqiang Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Tao Cheng Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Chen Jinhu Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Zhu Jian Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Lu Jie Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Bai Tong Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Zhang Guifang Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Liu Tonghai Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China  
Yin Yong Department of Radiation Oncology Physics, Shandong Cancer Hospital Affiliated to Shandong University, Jinan 250117, China yongyinsd@163.com 
Hits: 2477
Download times: 1204
Abstract::
      Objective To analyze the dosimetric and delivery efficiency differences between IMRT plans based on Halcyon and Trilogy Accelerator for left side breast cancer. Methods A total of 10 patients with left side breast cancer based on the Trilogy platform were retrospectively analyzed. For each patient,plan based on Halcyon was redesigned using Eclipse Version 15.1 TPS. In order to evaluate plan quality, dose coverage of target and dose to organs at risk, monitor unit efficiency, segment size and delivery time were compared. Results Halcyon treatment platform could meet the clinical objective. Dose distribution of the target volume had no significant difference with the Trilogy plans (P>0.05). Volumes receiving 10 Gy,20 Gy and Dmean of the left lung were significantly reduced(Z=-2.22--1.78, P<0.05). V5 of heart for Halcyon and Trilogy was(27.80±7.66)% and (23.18±8.19)%, respectively(Z=-0.71, P<0.05), while Dmean was (7.03±1.8)Gy and(7.11±2.40)Gy, respectively(P>0.05). Halcyon increased the monitor unit from 1 526.2±227.7 by Trilogy to 1 770.5±383.9(Z=-0.71, P<0.05), but decreased the delivery time from (12.38±1.49)min by Trilogy to (3.01±0.28)min(Z=-3.42, P<0.05). Conclusion Halcyon treatment platform can meet the clinical requirements, reduce dose to normal tissue with high delivery efficiency.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9075349  On-line:0

v
Scan QR Code
&et=B51BA772F0A51E0683DE60C76F50BA6616973688AD8E1563435121C4A5AF210745024C517F218BE564E910E4BADF6EDE91C127B28420DC69AF541A902203D5EE50F7C06543295BC873A14AA861F4325F483C0225087E495F8DFDC1311E45CD78553C02C37CC84D31B09FADD27F1411B65D2E5AD7D59EE51DEF9224F2D5DABB7B1A546AA27EF8949E&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B6351343F4791CA3&aid=7BA62EAAEF4CF3CAC19ABCAAAA15AD76&vid=&iid=5D311CA918CA9A03&sid=2C20277AC27E4821&eid=54E527C5B72E59D8&fileno=20190810&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B6351343F4791CA3"; var my_aid="7BA62EAAEF4CF3CAC19ABCAAAA15AD76";